Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase

被引:64
|
作者
Toth, Marietta [1 ]
Kun, Sandor [1 ]
Bokor, Eva [1 ]
Benltifa, Mahmoud [2 ,3 ,4 ]
Tallec, Gaylord [2 ,3 ,4 ]
Vidal, Sebastien [2 ,3 ,4 ]
Docsa, Tibor [5 ]
Gergely, Pal [6 ]
Somsak, Laszlo [1 ]
Praly, Jean-Pierre [2 ,3 ,4 ]
机构
[1] Univ Debrecen, Dept Organ Chem, H-4010 Debrecen, Hungary
[2] Univ Lyon, Inst Chim & Biochim Mol & Supramol, CNRS, Lab Chim Organ 2,UMR 5246, F-69622 Villeurbanne, France
[3] Univ Lyon 1, F-69622 Villeurbanne, France
[4] CPE Lyon, F-69616 Villeurbanne, France
[5] Univ Debrecen, Cell Biol & Signaling Res Grp, Hungarian Acad Sci, Dept Med Chem,Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[6] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
C-Glycosyl compounds; 1,3,4-Oxadiazoles; 1,2,4-Oxadiazoles; Glycogen phosphorylase; Inhibitors; TYPE-2; DIABETES-MELLITUS; 2,5-DISUBSTITUTED 1,3,4-OXADIAZOLES; ANTIDIABETIC AGENTS; EVOLVING EPIDEMIC; TARGETS; BINDING; MUSCLE; CYANIDES; THERAPY; AMIDES;
D O I
10.1016/j.bmc.2009.04.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of per-O-benzoylated 5-beta-D-glucopyranosyl-2-substituted-1,3,4-oxadiazoles was prepared by acylation of the corresponding 5-(beta-D-glucopyranosyl) tetrazole. As an alternative, oxidation of 2,6-anhydro-aldose benzoylhydrazones by iodobenzene I, I-diacetate afforded the same oxadiazoles. 1,3-Dipolar cycloaddition of nitrile oxides to per-O-benzoylated beta-D-glucopyranosyl cyanide gave the corresponding 5-beta-D-glucopyranosyl-3-substituted-1,2,4-oxadiazoles. The O-benzoyl protecting groups were removed by base-catalyzed transesterification. The 1,3,4-oxadiazoles were practically inefficient as inhibitors of rabbit muscle glycogen phosphorylase b while the 1,2,4-oxadiazoles displayed inhibitory activities in the micromolar range. The best inhibitors were the 5-beta-D-glucopyranosyl-3-(4-methylphenyl-and -2-naphthyl)- 1,2,4-oxadiazoles (K-i = 8.8 and 11.6 mu M, respectively). A detailed analysis of the structure-activity relationships is presented. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4773 / 4785
页数:13
相关论文
共 50 条
  • [41] Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents
    Yadav, Veena D. D.
    Boshoff, Helena I. I.
    Trifonov, Lena
    Roma, Jose Santinni O.
    Ioerger, Thomas R. R.
    Barry, Clifton E. E.
    Oh, Sangmi
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (09): : 1275 - 1283
  • [42] Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase α inhibitors
    Kuramochi, Kouji
    Fukudome, Keishi
    Kuriyama, Isoko
    Takeuchi, Toshifumi
    Sato, Yoshihiro
    Kamisuki, Shinji
    Tsubaki, Kazunori
    Sugawara, Fumio
    Yoshida, Hiromi
    Mizushina, Yoshiyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7227 - 7238
  • [43] Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
    Lu, Guo-Liang
    Tong, Amy S. T.
    Conole, Daniel
    Sutherland, Hamish S.
    Choi, Peter J.
    Franzblau, Scott G.
    Upton, Anna M.
    Lotlikar, Manisha U.
    Cooper, Christopher B.
    Denny, William A.
    Palmer, Brian D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
  • [44] Synthesis and Structure-Activity Relationships of a Class of Sodium Iodide Symporter Function Inhibitors
    Waltz, Fanny
    Pillette, Lucie
    Verhaeghe, Elodie
    Ambroise, Yves
    CHEMMEDCHEM, 2011, 6 (10) : 1775 - 1777
  • [45] Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors
    Lv, Peng-Cheng
    Sun, Juan
    Luo, Yin
    Yang, Ying
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4657 - 4660
  • [46] Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors
    Lombardo, LJ
    Camuso, A
    Clark, J
    Fager, K
    Gullo-Brown, J
    Hunt, JT
    Inigo, I
    Kan, D
    Koplowitz, B
    Lee, F
    McGlinchey, K
    Qian, LG
    Ricca, C
    Rovnyak, G
    Traeger, S
    Tokarski, J
    Williams, DK
    Wu, LI
    Zhao, YF
    Manne, V
    Bhide, RS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1895 - 1899
  • [47] Design, Synthesis, and Structure-Activity Relationships of Pyridoquinazolinecarboxamides as RNA Polymerase I Inhibitors
    Colis, Laureen
    Ernst, Glen
    Sanders, Sara
    Liu, Hester
    Sirajuddin, Paul
    Peltonen, Karita
    DePasquale, Michael
    Barrow, James C.
    Laiho, Marikki
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4950 - 4961
  • [48] Design, synthesis and structure-activity relationships of carbohydrazide based cathepsin K inhibitors
    Thompson, SK
    Tomaszek, TA
    Tew, DG
    Levy, MA
    Smith, WW
    Zhao, B
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    DesJarlais, RL
    Abdel-Meguid, SS
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U287 - U287
  • [49] Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX)
    East, James E.
    Kennedy, Andrew J.
    Tomsig, Jose L.
    De Leon, Alexandra R.
    Lynch, Kevin R.
    Macdonald, Timothy L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7132 - 7136
  • [50] Design, synthesis and structure-activity relationships of potent B-RAF inhibitors
    Namdev, Nivedita
    Lapierre, Jean-Marc
    Liu, Yanbin
    Wu, Hui
    Brassard, Chris
    Westlund, Neil
    Tandon, Manish
    Link, Jeff
    Kizer, Darin
    Nicewonger, Robb
    Bresciano, Karen
    Hall, Terence
    Szwaya, Jeff
    Chen, Chang-Rung
    France, Dennis
    Ashwell, Mark A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240